In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Natriuretic peptides: role for risk prediction and treatment efficacy

European Association of Preventive Cardiology webinar

07/10/2021 18:00 07/10/2021 19:00 Europe/Paris Natriuretic peptides: role for risk prediction and treatment efficacy

Access event page

European Association of Preventive Cardiology contact@escardio.org DD/MM/YYYY
European Association of Preventive Cardiology
Cardiovascular Risk Assessment
Preventive Cardiology
Risk Factors and Prevention
Online
event

Summary

Join Profs. Winfried März, Burkert Pieske, Marco Guazzi and Dr. Reijo Laaksonen

 

Focus on

Needs assessment and expected educational outcome

To foster knowledge about novel biomarkers which have emerged as a scientifically relevant field – in addition to classical risk factors – in improving risk prediction and outcome of cardiovascular disease. The European Association of Preventive Cardiology (EAPC – the ‘risk factor association’) is dedicated to extending knowledge of cardiovascular risk factors and treatment options among medical professionals, political stakeholders, and the public. Therefore, the EAPC has proposed a series of online resources and webinars on biomarkers, an approach of personalised medicine that will certainly be crucial in reducing the burden of cardiovascular disease.

Learning objectives

After watching this webinar, participants will understand:

  • the wide spectrum of cardiovascular risk biomarkers;
  • how to validate cardiovascular risk factor profiles in the healthy and diseased population;
  • how to differentiate and weigh the role of classical, as well as novel risk factors;
  • how to value methodological and clinical issues of biomarker assessment; and
  • how to apply novel risk biomarkers in clinical practice.

 



Register now

Free for everyone.

Faculty

Speakers

Winfried_März_2021.jpgProfessor Winfried März
Synlab Akademie
Mannheim, Germany

placeholder-faces.jpgProfessor Burkert, FESC
Charite University Medicine 
Berlin, Germany

placeholder-faces.jpgProfessor Reijo Laaksonen, FESC
Zora Biosciences Oy
Espoo, Finland

Host

placeholder-faces.jpgProfessor Marco Guazzi , FESC
IRCCS Polyclinic San Donato
Milano, Italy

 

Session information

This webinar is designed for physicians but also cardiologists wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

An application has been made to the EACCME® for CME accreditation of this event.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).